Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2023-10-16 00:00:00 ET · period of report 2023-10-13 · accession 0001569769-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-16 | 2023-10-13 | SMMT | Soni Manmeet Singh | COO, Dir | P - Purchase | $1.68 | +2.98M | 2.98M | New | +$5.00M |
| D | 2023-10-16 | 2023-10-13 | SMMT | Soni Manmeet Singh | COO, Dir | A - Grant | — | +14.00M | 14.00M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-13 | P | A | 2,976,190 | $1.68 | 2,976,190 | D | — | — | (F1) The Issuer entered into a securities purchase agreement with the Reporting Person, pursuant to which the Issuer agreed to issue and sell to the Reporting Person shares of the Issuer's Common Stock at a per share purchase price equal to $1.68. |
| 2 | Derivative | Stock Option (right to buy) | 2023-10-13 | A | A | 14,000,000 | — | 14,000,000 | D | $1.68 · — to 2033-10-13 | 14,000,000 Common Stock | (F3) Not applicable. (F2) The option was granted on October 13, 2023. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on October 13, 2024. Note this does not include an additional 14,000,000 options which were granted on October 13, 2023 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets. |